Keratosis Pilaris Atrophicans Faciei: Symptoms, Causes & UK Management

Keratosis Pilaris Atrophicans Faciei (KPAF), also historically referred to as ulerythema ophryogenes, is an uncommon skin condition that belongs to a group of disorders characterized by follicular keratosis—where the skin produces too much keratin, blocking hair follicles. While common keratosis pilaris (often called 'chicken skin') is widespread and harmless, KPAF is a rarer variant that specifically affects the face and can lead to atrophy (skin thinning) and scarring.

In the UK, this condition is usually identified in infants or young children, though it can persist or even first be diagnosed in adolescents. The primary hallmark is persistent redness (erythema) and small, sandpaper-like bumps that eventually lead to the loss of hair, most notably in the outer thirds of the eyebrows.

Identifying KPAF early is essential because the resulting scars and hair loss are permanent. Patients in the UK should look for the following progression of symptoms:

• Persistent Redness: A constant flushed appearance on the cheeks and the skin beneath the eyebrows.
• Follicular Papules: Tiny, hard bumps that feel rough to the touch, centered around hair follicles.
• Eyebrow Thinning: Loss of hair starting at the outer edges of the eyebrows (alopecia).
• Pitted Scarring: As the inflammation subsides, the skin may appear indented or 'worm-eaten' (atrophoderma vermiculatum).

According to NHS clinical knowledge, while the condition is predominantly cosmetic, the psychological impact on children and teenagers due to facial redness and eyebrow loss can be significant.

The exact cause of KPAF is not fully understood, but it is widely accepted to be a genetic condition. It often follows an autosomal dominant inheritance pattern, meaning if one parent has a history of severe keratosis pilaris or KPAF, there is a 50% chance of passing it to their children. The underlying mechanism involves the abnormal keratinisation of the follicular orifice, which creates a 'plug' that triggers inflammatory responses, eventually destroying the hair bulb and the surrounding dermal tissue.

It is frequently associated with other conditions such as atopic eczema, and in some rare cases, it may be linked to specific genetic syndromes like Noonan syndrome or Cornelia de Lange syndrome. However, for most British patients, it occurs as an isolated skin concern.

There is currently no absolute cure for Keratosis Pilaris Atrophicans Faciei, but management strategies aimed at reducing inflammation can limit the degree of scarring. Following NICE (National Institute for Health and Care Excellence) principles for inflammatory skin disorders, treatment usually involves a tiered approach:

Topical Keratolytics

Creams containing urea, salicylic acid, or lactic acid can help soften the keratin plugs and improve skin texture. These are often available over-the-counter in UK pharmacies or via prescription.

Topical Retinoids

Prescription retinoids, such as tretinoin or adapalene, may be used to regulate skin cell turnover. These must be used with caution on the face, particularly in children, due to the risk of irritation.

Anti-inflammatory Agents

In cases of significant redness, mild topical steroids or calcineurin inhibitors (like tacrolimus) may be prescribed for short periods to dampen the immune response and prevent further destruction of hair follicles.

Laser Therapy

Once the active inflammation has passed, UK dermatologists may suggest Pulse Dye Laser (PDL) to reduce persistent redness or fractional CO2 lasers to improve the appearance of pitted scarring.

If you or your child are experiencing persistent facial redness accompanied by rough skin and thinning eyebrows, you should speak to a GP online or in person. Early intervention is the only way to prevent permanent hair loss in the eyebrow region.

A consultation with a UK online doctor can provide a convenient way to get an initial assessment. During the video or photo-based consultation, the doctor can:

• Review the history of the rash and check for family links.
• Differentiate KPAF from other conditions like acne, rosacea, or seborrhoeic dermatitis.
• Provide advice on suitable emollient regimes and soap substitutes.
• Issue private prescriptions for medicated creams if appropriate.
• Advise if a referral to a consultant dermatologist is necessary for advanced treatments like isotretinoin or laser therapy.

Managing the condition daily involves protecting the skin barrier. UK patients are advised to:

• Avoid Harsh Soaps: Use soap-free cleansers to prevent drying out the skin, which can make the bumps feel rougher.
• Sun Protection: Use a high-SPF, non-comedogenic sunscreen daily. Sun exposure can worsen the appearance of erythema (redness).
• Gentle Exfoliation: Never scrub the face with harsh physical exfoliants, as this increases inflammation and the risk of scarring.
• Moisturise Regularly: Use creams containing ceramides to help maintain the skin's natural protective layer.